Iterum Therapeutics plc (ITRM) — key financial figures for fiscal year 2024 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:

Net Income/Loss (FY2024)

-$24.8M

Total Assets (FY2024)

$44.6M

Total Equity (FY2024)

-$4.1M

Cash Flows from Operating Activities (FY2024)

-$26.8M

Source: Iterum Therapeutics plc 10-K filing (FY2024). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.